Work

Disparity between scientific accomplishment and biotechnology availability in Brazil

Year: 2021

Type: article

Abstract: Despite being among the world's leaders in scientific output, Brazil ranks 66th among countries in the production of reagents and supplies needed for state-of-the-art scientific analyses. The production of needed reagents and equipment for experimental analyses and patient diagnostics is sorely lacking within Brazil and explicit in this pandemic period caused by SARS-CoV-2. A significant fraction of resources from Brazilian funding agencies is now being transferred to companies in other countries for the purchase of essential scientific-related products. Is this sustainable? Therefore it is necessary to draw the attention of all the world and Brazilian society about this situation.

Source: Science Progress

DOI: 10.1177/00368504211028373

Authors: Lucia Maria Almeida Braz, Roozbeh Tahmasebi, Antonio Charlys da Costa, Steven S Witkin

Institutions: Universidade de São Paulo, Weill Cornell Medicine

Language: English

Topic: Biotechnology and Related Fields

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Industry, innovation and infrastructure, Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500